These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1887672)

  • 1. OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis.
    Sansonetti PJ; Arondel J; Fontaine A; d'Hauteville H; Bernardini ML
    Vaccine; 1991 Jun; 9(6):416-22. PubMed ID: 1887672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.
    Sansonetti PJ; Arondel J
    Vaccine; 1989 Oct; 7(5):443-50. PubMed ID: 2683460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Res Microbiol; 1990; 141(7-8):907-12. PubMed ID: 2101481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y.
    Ahmed ZU; Sarker MR; Sack DA
    Vaccine; 1990 Apr; 8(2):153-8. PubMed ID: 2186582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.
    Bernardini ML; Arondel J; Martini I; Aidara A; Sansonetti PJ
    Infect Immun; 2001 Feb; 69(2):1072-83. PubMed ID: 11160004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an auxotrophic oral live Shigella flexneri vaccine.
    Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
    Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.
    Coster TS; Hoge CW; VanDeVerg LL; Hartman AB; Oaks EV; Venkatesan MM; Cohen D; Robin G; Fontaine-Thompson A; Sansonetti PJ; Hale TL
    Infect Immun; 1999 Jul; 67(7):3437-43. PubMed ID: 10377124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
    Kärnell A; Sweiha H; Lindberg AA
    Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
    Verma NK; Lindberg AA
    Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of shigellosis: from molecular and cellular biology of epithelial cell invasion to tissue inflammation and vaccine development.
    Sansonetti PJ
    Jpn J Med Sci Biol; 1998; 51 Suppl():S69-80. PubMed ID: 10211438
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentials of Shigella flexneri Y strain TSF21 as a candidate vaccine against shigellosis: safety, immunogenicity and protective efficacy in Bonnet monkeys.
    Ashraf MM; Giri DK; Batra HV; Khandekar P; Ahmed ZU; Talwar GP
    FEMS Microbiol Immunol; 1991 Jun; 3(3):165-70. PubMed ID: 1878259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
    Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shigella flexneri infection: pathogenesis and vaccine development.
    Jennison AV; Verma NK
    FEMS Microbiol Rev; 2004 Feb; 28(1):43-58. PubMed ID: 14975529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
    Shim DH; Suzuki T; Chang SY; Park SM; Sansonetti PJ; Sasakawa C; Kweon MN
    J Immunol; 2007 Feb; 178(4):2476-82. PubMed ID: 17277155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
    Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
    Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.